DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Voclosporin is an investigational drug.
There have been 16 clinical trials for Voclosporin. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.
The most common disease conditions in clinical trials are Nephritis, Lupus Nephritis, and Dry Eye Syndromes. The leading clinical trial sponsors are Aurinia Pharmaceuticals Inc., Lux Biosciences, Inc., and Weill Medical College of Cornell University.
Recent Clinical Trials for Voclosporin
|Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome||Aurinia Pharmaceuticals Inc.||Phase 2/Phase 3|
|Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease||Aurinia Pharmaceuticals Inc.||Phase 2|
|Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis||Aurinia Pharmaceuticals Inc.||Phase 2|